Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,761 | 5,646 | 15,345 | 2,012 | 5,708 |
| Gross Profit | 2,761 | 5,646 | 15,345 | 2,012 | 5,708 |
| Operating Expenses | 23,959 | 1,739 | 32,212 | 36,540 | 31,101 |
| Operating Income | -21,198 | 3,907 | -16,867 | -34,528 | -25,393 |
| Interest Expense | 106 | 101 | 5 | 6 | 7 |
| Other Income | 81 | 354 | 24 | 66 | 46 |
| Pre-tax Income | -21,223 | 4,160 | -16,848 | -34,468 | -25,354 |
| Income Tax | -310 | 4,462 | -1,308 | -2,079 | -1,634 |
| Net Income Continuous | -20,913 | -302 | -15,540 | -32,389 | -23,720 |
| Net Income | $-20,913 | $-302 | $-15,540 | $-32,389 | $-23,720 |
| EPS Basic Total Ops | -6.48 | 1.62 | -4.86 | -10.08 | -7.38 |
| EPS Basic Continuous Ops | -6.44 | 1.63 | -4.83 | -10.09 | -7.40 |
| EPS Diluted Total Ops | -6.48 | 1.62 | -4.86 | -10.08 | -7.38 |
| EPS Diluted Continuous Ops | -6.44 | 1.63 | -4.83 | -10.09 | -7.40 |
| EBITDA(a) | $-20,838 | $3,778 | $-16,535 | $-33,919 | $-24,798 |